Oncotelic Therapeutics, Inc. (OTLC): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$170.4K
As of 2023-12-31
-28.9%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $170.4K | -29.4% | 2024-04-12, Balance as of period end |
| 2022-12-31 | $241.5K | -57.5% | 2024-04-12, Balance as of period end |
| 2021-12-31 | $568.8K | +20.0% | 2023-04-20, Balance as of period end |
| 2020-12-31 | $474.0K | +478.3% | 2022-04-15, Balance as of period end |
| 2019-12-31 | $82.0K | n/m | 2021-04-15, Balance as of period end |
| 2018-12-31 | $2.5K | -99.8% | 2020-05-14, Balance as of period end |
| 2017-12-31 | $1.11M | -68.5% | 2019-04-10, Balance as of period end |
| 2016-12-31 | $3.54M | -87.0% | 2018-04-17, Balance as of period end |
| 2015-12-31 | $27.29M | n/a | 2017-03-30, Balance as of period end |
| No annual figure between 2012-12-31 and 2015-12-31. | |||
| 2012-12-31 | $4.95M | -50.4% | 2013-03-15, Balance as of period end |
| 2011-12-31 | $9.97M | +116.7% | 2013-03-15, Balance as of period end |
| 2010-12-31 | $4.60M | -67.0% | 2013-03-15, Balance as of period end |
| 2009-12-31 | $13.93M | n/a | 2012-03-28, Balance as of period end |